Orchestra BioMed Holdings, Inc. (OBIO)
NASDAQ: OBIO · Real-Time Price · USD
4.960
-0.300 (-5.70%)
Dec 5, 2024, 4:00 PM EST - Market closed
Orchestra BioMed Holdings Analyst Ratings
Total Analysts
4
Consensus Rating
Strong Buy
Price Target
$15.75
Upside
+217.54%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $14 | Strong Buy | Reiterates | $14 | +182.26% | Nov 15, 2024 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $20 | Strong Buy | Maintains | $20 | +303.23% | Nov 13, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $14 | Strong Buy | Initiates | $14 | +182.26% | Aug 22, 2024 |
| B. Riley Securities | B. Riley Securities | Strong Buy Initiates $15 | Strong Buy | Initiates | $15 | +202.42% | Jul 25, 2024 |
| Chardan Capital | Chardan Capital | Strong Buy Reiterates $20 | Strong Buy | Reiterates | $20 | +303.23% | Jun 12, 2024 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $20 | Strong Buy | Maintains | $20 | +303.23% | Mar 28, 2024 |
| Jefferies | Jefferies | Strong Buy Initiates $14 | Strong Buy | Initiates | $14 | +182.26% | Jan 19, 2024 |
| Chardan Capital | Chardan Capital | Strong Buy Reiterates $20 | Strong Buy | Reiterates | $20 | +303.23% | Aug 11, 2023 |
| Chardan Capital | Chardan Capital | Strong Buy Reiterates $20 | Strong Buy | Reiterates | $20 | +303.23% | Aug 9, 2023 |
| Chardan Capital | Chardan Capital | Strong Buy Reiterates $20 | Strong Buy | Reiterates | $20 | +303.23% | May 15, 2023 |
| Piper Sandler | Piper Sandler | Buy Initiates $15 | Buy | Initiates | $15 | +202.42% | Feb 24, 2023 |
| Chardan Capital | Chardan Capital | Strong Buy Initiates $20 | Strong Buy | Initiates | $20 | +303.23% | Feb 7, 2023 |